Financial Program | SOMAVERT® (pegvisomant for injection) | Safety Info

How the Pfizer Bridge Program works

Your doctor prescribes SOMAVERT and, with your permission, submits your information on a SOMAVERT Patient Enrollment Form and the insurance information they have in your file to the Pfizer Bridge Program^*.

Your Patient Care Consultant (PCC) contacts you to:

Get any additional information that is needed
Answer your insurance or reimbursement questions

You can help speed the process by having the following current information ready when your PCC calls:

A copy of your insurance card, which you can get from your employer or insurance company
The policy holder's name, address, and date of birth

Your PCC verifies your coverage and requests treatment authorization for SOMAVERT, if your insurance company allows. If your insurance company has approved the medicine, your PCC sends the prescription to the pharmacy, and the pharmacy contacts you to set up delivery of SOMAVERT directly to your home.

Your PCC will look for other ways to help get coverage if your insurance benefits do not cover therapy with SOMAVERT. Your PCC may also help you appeal the decision. This means he or she asks your insurance company to extend your coverage to include SOMAVERT treatment.

Calls about insurance reimbursement are welcome during the hours of 9 AM to 7 PM Eastern Time at 1-800-645-1280.

^*Certain programs and services powered by Pfizer RxPathways^®.

Close-up photo of Dallas, an actual acromegaly patient, smiling

“I worked with the Pfizer Bridge Program, who helped arrange for somebody to come and train me on how to do the injections.”^†

—Dallas, a patient with acromegaly

^†If requested by your doctor, a nurse can come to your home to teach you how to inject SOMAVERT.

content-footer

IMPORTANT SAFETY INFORMATION

Click to expand

Do not use SOMAVERT^® (pegvisomant for injection) if you are allergic to SOMAVERT or anything that is in it.

Be sure to tell your doctor if you use narcotic painkillers (opioid medicines) because the dose of SOMAVERT may need to be changed.

Blood sugar levels may go down when taking SOMAVERT. Be sure to tell your doctor if you use insulin or other medicines (oral hypoglycemic medicines) for diabetes. The dose of these medicines may need to be reduced when you use SOMAVERT.

Some people who have used SOMAVERT have developed liver problems. These problems generally disappeared when those people stopped taking SOMAVERT.

Stop the drug right away and call your doctor if you get any of these symptoms:

Your skin or the white part of your eyes turns yellow (jaundice)
Your urine turns dark
Your bowel movements (stools) turn light in color
You do not feel like eating for several days
You feel sick to your stomach (nausea)
You have unexplained tiredness
You have pain in the stomach area (abdomen)

Your doctor may do blood tests before and during your treatment with SOMAVERT to check that the IGF-I levels in your blood are normal and/or that your liver is working correctly. Your dose of SOMAVERT may be changed based on the results of these tests.

If you have stopped SOMAVERT because of an allergic reaction, your doctor will carefully monitor what happens if you start SOMAVERT again.

The most common side effects with SOMAVERT are infection, pain, nausea, diarrhea, abnormal liver function tests, flu-like symptoms, and reaction at the injection site. These are not all of the possible side effects of SOMAVERT. For more information, speak to your doctor.

Inject SOMAVERT in a different place on your body each day. This can help prevent skin problems such as lumpiness or soreness.

SOMAVERT has not been studied in pregnant women. It is not known if SOMAVERT passes into the mother’s milk or if it can harm the baby.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.

INDICATION

SOMAVERT is a prescription medicine for acromegaly. It is for patients whose disease has not been controlled by surgery or radiation, or patients for whom these options are not appropriate. The goal of treatment with SOMAVERT is to have a normal IGF-I level in the blood.

This site is intended only for U.S residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.

ISI